Clinical trial
Efficacy and Safety of Combination Moxidectin and Albendazole, Ivermectin and Albendazole and Albendazole Alone in Adolescents and Adults Infected With Trichuris Trichiura: a Randomized Controlled Trial
NCT04726969 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Combination Moxidectin and Albendazole, Ivermectin and Albendazole and Albendazole Alone in Adolescents and Adults Infected With Trichuris Trichiura: a Randomized Controlled Trial
- Lead sponsor
- Jennifer Keiser
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 15, 2021
- Completion date
- September 9, 2021
- Enrollment
- 255 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.